Qr. Huang et N. Manolios, Investigation of the-1377 polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification, PATHOLOGY, 32(2), 2000, pp. 126-130
Apoptosis mediated by the Apo-1/Fas and Fas ligand pathways has been implic
ated in many disorders, including autoimmunity and tumorigenesis. The recen
t identification of two polymorphisms on the 5' flanking region of the huma
n Apo-1/Fas gene has provided useful markers for investigation of the genet
ic contribution of the Apo-1/Fas gene in these diseases. The Mval polymorph
ism at the -670 nucleotide position is frequent in the normal population, w
ith 51% heterozygosity. The other polymorphism, a result of single nucleoti
de G --> A substitution at the -1377 position, does not create or delete an
y restriction enzyme digestion sites. In this paper, we describe a simple a
nd rapid method for detecting the -1377 polymorphism by using allele-specif
ic amplification (ASA). Using the ASA method, the -1377 polymorphism in a n
ormal Caucasian population was characterised. Frequencies of 0.13 and 0.87
for allele A and G, respectively, were observed and the homozygosity of the
mutant allele (A) was found in only 2% of the population. We subsequently
examined the -1377 polymorphism in sporadic systemic lupus erythematosus (S
LE) patients (n = 86). The results showed that both genotype distribution a
nd allele frequencies in SLE patients were similar to that in controls, sug
gesting that the -1377 promoter polymorphism is unlikely to be associated w
ith SLE susceptibility. The description of this rapid detection method and
characterisation of the -1377 polymorphism are useful means for future gene
tic studies in diseases in which the Fas-mediated apoptosis may be involved
.